Production of passive immunity in neonatal ferrets following maternal vaccination with killed influenza A virus vaccines
- PMID: 3817868
- PMCID: PMC1453355
Production of passive immunity in neonatal ferrets following maternal vaccination with killed influenza A virus vaccines
Abstract
Neonatal ferrets may be passively immunized following maternal vaccination with formalin-inactivated influenza A virus vaccine, but the level of protection from partial to complete depends upon the number of doses used to vaccinate the mother, the presence or absence of aluminum hydroxide adjuvant, whether or not the mothers were 'primed' by prior infection with a serologically heterologous type A virus, and the age of the neonate at challenge. Neonates were completely protected up to 2 weeks of age, but susceptibility returned to nasal epithelium at 5 weeks and to lung at 7 weeks. Mothers immunized up to 9 months previously also partially or completely protected their offspring, this correlating with the maternal serum haemagglutination-inhibition (HI) antibody titre at the time of neonatal challenge, not the duration of immunity.
Similar articles
-
Assessment of resistance to influenza virus infection in animal models.Dev Biol Stand. 1975;28:307-18. Dev Biol Stand. 1975. PMID: 1126574
-
Role of maternal immunity in the protection of newborn ferrets against infection with a virulent influenza virus.Immunology. 1984 Jul;52(3):389-94. Immunology. 1984. PMID: 6745992 Free PMC article.
-
Maternal-infant transfer of influenza-specific immunity not detectable by haemagglutination inhibition.Microbios. 1988;54(220-221):135-47. Microbios. 1988. PMID: 2846987
-
Immunity in neonates.Vet Immunol Immunopathol. 2002 Sep 10;87(3-4):207-13. doi: 10.1016/s0165-2427(02)00078-8. Vet Immunol Immunopathol. 2002. PMID: 12072236 Review.
-
Protection of newborn animals through maternal immunization.J Comp Pathol. 2007 Jul;137 Suppl 1:S32-4. doi: 10.1016/j.jcpa.2007.04.009. Epub 2007 Jun 7. J Comp Pathol. 2007. PMID: 17559866 Free PMC article. Review.
Cited by
-
Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization.Virol J. 2017 Jun 26;14(1):123. doi: 10.1186/s12985-017-0787-4. Virol J. 2017. PMID: 28651593 Free PMC article.
-
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.J Exp Med. 2011 Jan 17;208(1):181-93. doi: 10.1084/jem.20101352. Epub 2011 Jan 10. J Exp Med. 2011. PMID: 21220454 Free PMC article.
-
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.PLoS Med. 2007 May;4(5):e178. doi: 10.1371/journal.pmed.0040178. PLoS Med. 2007. PMID: 17535101 Free PMC article.
-
Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: A viable alternative to oseltamivir.MAbs. 2016 Aug-Sep;8(6):1156-66. doi: 10.1080/19420862.2016.1183083. Epub 2016 May 11. MAbs. 2016. PMID: 27167234 Free PMC article.
-
Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.J Virol. 1990 Mar;64(3):1370-4. doi: 10.1128/JVI.64.3.1370-1374.1990. J Virol. 1990. PMID: 2304146 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical